| ID | 1610 | |
| PMID | 18031459 | |
| Year | 2007 | |
| Sequence | SRRRRRRRRR | |
| Name | SR9 | |
| Length | 10 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | Synthesized using plasmids | |
| Nature of Peptide/Cargo | Not mentioned | |
| Mechanism | Not mentioned | |
| Cargo Sequence/Structure | MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK | |
| Name of cargo | GFP | |
| Assay | Fluorescent microscopy and Confocal microscopy | |
| Enhancer | PBS , Oleic Acid | |
| Properties of enhancer | Oleic acid is a chemical enhancer | |
| Concentration | 14uM of GFP mixed with 42µM of peptide | |
| Incubation time | 1-60minutes | |
| Tissue permeability (value with units) | Fluorescence microscopy results showed fluorescence in the hypo dermis | |
| Tissue Sample | Backs of mice | |
| Ex vivo/In vivo/In vitro | in vitro | |
| STRUCTURE |
| |
| SMILES | N[C@@H](CO)C(=O)N[C@@H](CCCNC (=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C (=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H] (CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC (=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N) C(=O)N[C@@H](CCCNC(=[NH2])N) C(=O)N[C@@H](CCCNC(=[NH2])N) C(=O)N[C@@H](CCCNC(=[NH2])N)C=O | |